Actuate Therapeutics Inc beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.20 | — | — | Miss |
| Q1 FY2026 | $-0.23 | — | — | Miss |
| Q12026 FY2026 | $-0.23 | $-0.24 | -4.3% | Miss |
| 2026-03-12 | $-0.24 | — | — | Miss |
Back to ACTU overview · ACTU holders · ACTU KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.